Venous thromboembolism in adults

anticoagulant with the person having treatment, and to review and update the information, advice and support given when they started having anticoagulation treatment. [Adapted from NICE's guideline on venous thromboembolic diseases, recommendation 1.4.1 and expert opinion]. Review at least once a year A review of general health, risk of VTE recurrence, bleeding risk and treatment preferences and to review and update the information, advice and support given when they started treatment for people taking long-term anticoagulation treatment. [Adapted from NICE's guideline on venous thromboembolic diseases, recommendation 1.4.12] Equality and diversity considerations NICE's guideline on venous thromboembolic diseases covers people aged 18 and over because the evidence for the recommendations focused on this age group. This statement applies to people aged 18 and over, but clinical judgement should be used when treating people aged under 18 taking anticoagulation treatment after a VTE. Information given to people should be in a format that suits their needs and preferences. The reviews should be accessible to people who do not speak or read English, and it should be culturally appropriate and age appropriate. For people with additional needs related to a disability, impairment or sensory loss, information should also be provided as set out
